Mark Alan Goldberg

Insider Reports History

Location
Lexington, MA
Signature
/s/ Melissa Masse, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Alan Goldberg:

Company Role Class Num Shares Value Price $ Report Date Ownership
GLYCOMIMETICS INC Director Common Stock 24,828 $74,484 $3.00 29 Mar 2024 Direct
GLYCOMIMETICS INC Director Common Stock 11,497 $34,491 $3.00 29 Mar 2024 By family trusts
Blueprint Medicines Corp Director Common Stock 0 $0 $101.84 17 Jul 2025 Direct
ImmunoGen, Inc. Director Common Stock 0 $0 $29.30 12 Feb 2024 Direct
ImmunoGen, Inc. Director Deferred Share Unit 0 $0 $29.30 12 Feb 2024 Direct
ImmunoGen, Inc. Director Restricted Stock Unit 0 $0 $29.30 12 Feb 2024 Direct
GLYCOMIMETICS INC Director Stock Option (right to buy) 40,000 01 May 2024 Direct
IDERA PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 26,000 23 Jun 2022 Direct
Blueprint Medicines Corp Director Stock Option (Right to Buy) 0 17 Jul 2025 Direct
ImmunoGen, Inc. Director Stock Option (Right to Buy) 0 $5.19 12 Feb 2024 Direct

Insider Reports Filed by Mark Alan Goldberg

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BPMC Blueprint Medicines Corp 17 Jul 2025 10 $0 4 Director 21 Jul 2025, 19:46
BPMC Blueprint Medicines Corp 18 Jun 2025 1 +$499,924 4 Director 24 Jun 2025, 16:26
BPMC Blueprint Medicines Corp 12 Jun 2024 2 $0 4 Director 14 Jun 2024, 17:34
GLYC GLYCOMIMETICS INC 01 May 2024 1 $0 4 Director 01 May 2024, 16:30
GLYC GLYCOMIMETICS INC 29 Mar 2024 1 +$13,752 4 Director 02 Apr 2024, 16:05
/report/000110465924014708-goldberg-mark-alan-2024-02-12 ImmunoGen, Inc. 12 Feb 2024 13 $0 4 Director 12 Feb 2024, 16:42
/report/000141588924000376-goldberg-mark-alan-2023-12-29 ImmunoGen, Inc. 29 Dec 2023 1 +$16,871 4 Director 03 Jan 2024, 17:45
GLYC GLYCOMIMETICS INC 29 Dec 2023 1 +$13,752 4 Director 02 Jan 2024, 16:05
/report/000141588923014675-goldberg-mark-alan-2023-10-30 ImmunoGen, Inc. 30 Oct 2023 3 -$3,800 4 Director 01 Nov 2023, 17:59
GLYC GLYCOMIMETICS INC 30 Sep 2023 1 +$13,750 4 Director 03 Oct 2023, 16:15
/report/000141588923013757-goldberg-mark-alan-2023-09-29 ImmunoGen, Inc. 29 Sep 2023 1 +$16,870 4 Director 02 Oct 2023, 17:05
/report/000141588923010821-goldberg-mark-alan-2023-06-30 ImmunoGen, Inc. 30 Jun 2023 1 +$16,870 4 Director 05 Jul 2023, 17:53
BPMC Blueprint Medicines Corp 21 Jun 2023 2 $0 4 Director 23 Jun 2023, 19:06
/report/000141588923009947-goldberg-mark-alan-2023-06-14 ImmunoGen, Inc. 14 Jun 2023 2 $0 4 Director 16 Jun 2023, 16:45
GLYC GLYCOMIMETICS INC 19 May 2023 1 $0 4 Director 22 May 2023, 16:23
/report/000141588923006057-goldberg-mark-alan-2023-03-31 ImmunoGen, Inc. 31 Mar 2023 1 +$16,873 4 Director 04 Apr 2023, 16:51
/report/000141588923000304-goldberg-mark-alan-2022-12-30 ImmunoGen, Inc. 30 Dec 2022 1 $0 4 Director 04 Jan 2023, 15:22
/report/000141588922010221-goldberg-mark-alan-2022-09-30 ImmunoGen, Inc. 30 Sep 2022 1 $0 4 Director 04 Oct 2022, 16:14
/report/000141588922007344-goldberg-mark-alan-2022-06-30 ImmunoGen, Inc. 30 Jun 2022 1 $0 4 Director 05 Jul 2022, 16:36
/report/000141588922006941-goldberg-mark-alan-2022-06-23 IDERA PHARMACEUTICALS, INC. 23 Jun 2022 1 $0 4 Director 27 Jun 2022, 16:31
BPMC Blueprint Medicines Corp 21 Jun 2022 2 $0 4 Director 30 Jun 2022, 21:55
/report/000141588922006735-goldberg-mark-alan-2022-06-15 ImmunoGen, Inc. 15 Jun 2022 2 +$148,280 4 Director 17 Jun 2022, 16:22
GLYC GLYCOMIMETICS INC 18 May 2022 1 $0 4 Director 20 May 2022, 16:08
/report/000117911022002691-goldberg-mark-alan-2022-03-31-restatement ImmunoGen, Inc. 31 Mar 2022 1 $0 4/A Director 20 Apr 2022, 17:38
BPMC Blueprint Medicines Corp 03 Mar 2022 1 +$299,900 4 Director 07 Mar 2022, 15:05
/report/000117911022000100-goldberg-mark-alan-2021-12-31 ImmunoGen, Inc. 31 Dec 2021 1 $0 4 Director 04 Jan 2022, 15:02
/report/000117911021009041-goldberg-mark-alan-2021-09-30 ImmunoGen, Inc. 30 Sep 2021 1 $0 4 Director 01 Oct 2021, 16:14
/report/000117911021007319-goldberg-mark-alan-2021-06-30 ImmunoGen, Inc. 30 Jun 2021 1 $0 4 Director 02 Jul 2021, 16:22
/report/000117911021006817-goldberg-mark-alan-2021-06-16 ImmunoGen, Inc. 16 Jun 2021 2 +$297,880 4 Director 17 Jun 2021, 16:23
/report/000141588921002918-goldberg-mark-alan-2021-06-08 IDERA PHARMACEUTICALS, INC. 08 Jun 2021 1 $0 4 Director 10 Jun 2021, 17:06
BPMC Blueprint Medicines Corp 02 Jun 2021 2 $0 4 Director 04 Jun 2021, 16:21
GLYC GLYCOMIMETICS INC 18 May 2021 2 $0 4 Director 27 May 2021, 20:51